MaxCyte, Inc. MXCT
1.17
(0.02)
(1.68%)
as of 25 Sep
- Market cap
- $122.8M
- P/E
- 0.0×
Follow MXCT
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (20.39%) | (21.30%) | (23.63%) | (23.19%) |
+8 more TTM periods Free account |
|
| (17.62%) | (18.43%) | (20.20%) | (19.75%) | ||
ROIC |
(49.23%) | (46.89%) | (47.39%) | (44.91%) | |
Return on Tangible Assets |
(28.22%) | (30.24%) | (36.69%) | (35.88%) | |
Average Days of Receivables |
46.10 | 48.00 | 38.71 | 88.08 | |
Free Cash Flow per Share |
(0.22) | (0.27) | (0.34) | (0.39) | |
Free Cash Flow |
(23.64) | (29.35) | (36.18) | (41.23) | |
Capital Expenditures |
(0.66) | (1.19) | (1.77) | (1.68) | |
Piotroski F-Score |
3.00 | 1.00 | 1.00 | 1.00 | |
| Other line items | |||||
Cash ROIC |
(8.69%) | (10.25%) | (12.53%) | (13.83%) | |
Accounts Receivable Turnover |
6.42 | 6.61 | 8.07 | 5.35 | |
Accounts Payable Turnover |
4.38 | 3.62 | 4.51 | 4.38 | |
Inventory Turnover |
0.82 | 0.79 | 0.76 | 0.77 | |
Average Days of Payables |
98.13 | 69.36 | 82.19 | 68.10 | |
Days of Inventory on Hand |
441.28 | 442.54 | 442.73 | 403.02 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
53.98% | 58.16% | 63.05% | 64.22% | |
Selling, General and Administrative Expense of Revenue |
125.49% | 130.73% | 142.43% | 150.31% | |
Share Based Compensation of Revenue |
15.98% | 22.66% | 27.90% | 33.82% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.64 | 0.72 | 0.77 | 0.87 | |
Depreciation/Fixed assets |
0.40 | 0.34 | 0.30 | 0.05 | |
Capex/Depreciation |
(0.11) | (0.21) | (0.34) | (1.84) | |
Revenue per Share |
0.29 | 0.30 | 0.31 | 0.32 | |
Operating CF per Share |
(0.22) | (0.26) | (0.32) | (0.37) | |
Capex per Share |
(0.01) | (0.01) | (0.02) | (0.02) | |
Capex to Sales |
0.02 | 0.04 | 0.05 | 0.05 | |
Net Profit Margin |
(114.77%) | (121.16%) | (135.14%) | (132.58%) |
Columns are period end dates